Scalper1 News
Strength in the IPO market continued Tuesday with three more companies in the health care sector filing to come public. Entellus Medical, which sells a minimally invasive balloon sinus dilation treatment for patients who suffer from chronic sinusitis, filed plans to raise up to $69 million in an initial public offering. Entellus plans to list on the Nasdaq under the ticker ENTL. Also filing for an IPO Tuesday was AltheaDx, a developer of molecular Scalper1 News
Scalper1 News